“Interferons in MS and COVID-19” Neuroimmunology and Neuroinflammation

Our lab’s article, “Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?” was published in Neuroimmunology and Neuroinflammation. You can read the paper here.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *